| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$37.79 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Guyer David R |
Chief Executive Officer |
• • – |
2015-05-28 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
18,582 |
|
- |
|
| Wheeler Kurt |
10% Owner |
– – • |
2015-05-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,554,744) |
0 |
|
- |
|
| Galakatos Nicholas |
Director |
– • – |
2015-05-26 |
4 |
A |
$0.00 |
$0 |
I/I |
3,137 |
7,945 |
|
- |
|
| Galakatos Nicholas |
Director |
– • – |
2015-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,319 |
15,204 |
|
- |
|
| Galakatos Nicholas |
Director |
– • – |
2015-05-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,554,744) |
0 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-05-18 |
4 |
AS |
$51.93 |
$623,498 |
D/D |
(12,000) |
0 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-05-18 |
4 |
OE |
$1.59 |
$19,116 |
D/D |
12,000 |
12,000 |
|
- |
|
| Wood Barbara A |
SVP, General Counsel,Secretary |
• – – |
2015-05-01 |
4 |
AS |
$45.88 |
$91,760 |
D/D |
(2,000) |
0 |
|
- |
|
| Wood Barbara A |
SVP, General Counsel,Secretary |
• – – |
2015-05-01 |
4 |
OE |
$24.49 |
$48,980 |
D/D |
2,000 |
2,000 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-04-29 |
4 |
AS |
$48.13 |
$900,295 |
D/D |
(18,582) |
0 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-04-29 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
18,582 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-04-17 |
4 |
AS |
$50.43 |
$605,622 |
D/D |
(12,000) |
0 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-04-17 |
4 |
OE |
$1.59 |
$19,116 |
D/D |
12,000 |
12,000 |
|
- |
|
| Bolte Axel |
Director |
– • – |
2015-03-30 |
4 |
B |
$48.27 |
$24,135 |
D/D |
500 |
2,500 |
2.39 |
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-03-30 |
4 |
AS |
$48.19 |
$896,817 |
D/D |
(18,582) |
0 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-03-30 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
18,582 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2015-03-25 |
4 |
OE |
$0.06 |
$806 |
D/D |
13,668 |
4,910,487 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2015-03-05 |
4 |
S |
$51.75 |
$52,008,750 |
D/D |
(1,005,000) |
4,896,819 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-03-02 |
4 |
AS |
$53.05 |
$988,987 |
D/D |
(18,582) |
0 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-03-02 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
18,582 |
|
- |
|
| Wood Barbara A |
SVP, General Counsel,Secretary |
• – – |
2015-03-02 |
4 |
AS |
$53.23 |
$106,512 |
D/D |
(2,000) |
0 |
|
- |
|
| Wood Barbara A |
SVP, General Counsel,Secretary |
• – – |
2015-03-02 |
4 |
OE |
$24.49 |
$48,980 |
D/D |
2,000 |
2,000 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-02-02 |
4 |
AS |
$51.59 |
$798,900 |
D/D |
(15,018) |
0 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-02-02 |
4 |
OE |
$10.03 |
$150,631 |
D/D |
15,018 |
15,018 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-01-02 |
4 |
AS |
$44.91 |
$681,696 |
D/D |
(15,034) |
0 |
|
- |
|
494 Records found
|
|
Page 16 of 20 |
|
|
